COEGIN PHARMA AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.89 SEK | +2.12% |
|
+2.48% | -46.33% |
| Sales 2021 | - | Sales 2022 | - | Capitalization | 96.51M 1.05B |
|---|---|---|---|---|---|
| Net income 2021 | -25M -272M | Net income 2022 | -35M -381M | EV / Sales 2021 | - |
| Net cash position 2021 | 25.66M 279M | Net cash position 2022 | 3.82M 41.53M | EV / Sales 2022 | - |
| P/E ratio 2021 |
-8.52
x | P/E ratio 2022 |
-2.71
x | Employees | 3 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 35.03% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.12% | ||
| 1 week | +2.48% | ||
| Current month | +5.55% | ||
| 1 month | +6.80% | ||
| 3 months | -9.35% | ||
| 6 months | -49.30% | ||
| Current year | -46.33% |
1 week
2.80
2.89
1 month
2.582.98
Current year
2.585.75
1 year
2.5813.90
3 years
2.5863.00
5 years
2.5863.00
10 years
2.5863.00
| Managers | Title | Age | Since |
|---|---|---|---|
Tore Duvold
CEO | Chief Executive Officer | 56 | 20-08-31 |
| Director of Finance/CFO | 49 | 22-03-31 | |
Berit Johansen
CTO | Chief Tech/Sci/R&D Officer | 66 | 04-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 20-08-31 | |
| Director/Board Member | 66 | 21-12-31 | |
| Director/Board Member | 62 | 23-04-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 2.89 | +2.12% | 11,132 |
| 24-04-24 | 2.83 | +1.07% | 13,752 |
| 24-04-23 | 2.8 | -2.78% | 21,506 |
| 24-04-22 | 2.88 | 0.00% | 7,887 |
| 24-04-19 | 2.88 | +2.13% | 23,600 |
End-of-day quote NORDIC GROWTH MARKET, April 24, 2024
More quotes
Coegin Pharma AB, formerly GoldBlue AB (publ) is a Sweden-based biotechnology company. The Company focuses on the development of small molecule therapies aimed at the key enzyme, which is known for its involvement in a variety of inflammatory diseases as well as in cancer. Coegin Pharma AB provides consulting and management services in drug development as well.
Calendar
2024-05-15
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -46.33% | 4.15M | |
| +1.12% | 43.84B | |
| +6.77% | 41.68B | |
| +45.26% | 41.25B | |
| -11.96% | 27.04B | |
| +6.01% | 25.53B | |
| -24.92% | 18.18B | |
| -3.63% | 12.29B | |
| +27.16% | 12.29B | |
| +7.30% | 11.15B |
- Stock Market
- Equities
- COEGIN Stock
